95 related articles for article (PubMed ID: 16713265)
21. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
Abouzid K; Shouman S
Bioorg Med Chem; 2008 Aug; 16(16):7543-51. PubMed ID: 18678492
[TBL] [Abstract][Full Text] [Related]
22. Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor.
Liechti C; Séquin U; Bold G; Furet P; Meyer T; Traxler P
Eur J Med Chem; 2004 Jan; 39(1):11-26. PubMed ID: 14987830
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase.
Asano T; Yoshikawa T; Nakamura H; Uehara Y; Yamamoto Y
Bioorg Med Chem Lett; 2004 May; 14(9):2299-302. PubMed ID: 15081028
[TBL] [Abstract][Full Text] [Related]
24. Towards predictive inhibitor design for the EGFR autophosphorylation activity.
San Juan AA
Eur J Med Chem; 2008 Apr; 43(4):781-91. PubMed ID: 17689836
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of F90, an epidermal growth factor receptor tyrosine kinase inhibitor, on glioblastoma cell line SHG-44.
Liu FJ; Gui SB; Li CZ; Sun ZL; Zhang YZ
Chin Med J (Engl); 2008 Sep; 121(17):1702-6. PubMed ID: 19024103
[TBL] [Abstract][Full Text] [Related]
26. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4-ones.
Xiao ZP; Li HQ; Shi L; Lv PC; Song ZC; Zhu HL
ChemMedChem; 2008 Jul; 3(7):1077-82. PubMed ID: 18433075
[TBL] [Abstract][Full Text] [Related]
28. Acryloylamino-salicylanilides as EGFR PTK inhibitors.
Deng W; Guo Z; Guo Y; Feng Z; Jiang Y; Chu F
Bioorg Med Chem Lett; 2006 Jan; 16(2):469-72. PubMed ID: 16275081
[TBL] [Abstract][Full Text] [Related]
29. A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors.
Lin WH; Song JS; Chang TY; Chang CY; Fu YN; Yeh CL; Wu SH; Huang YW; Fang MY; Lien TW; Hsieh HP; Chao YS; Huang SF; Tsai SF; Wang LM; Hsu JT; Chen YR
Anal Biochem; 2008 Jun; 377(1):89-94. PubMed ID: 18358823
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 2-aryl-8-hydroxy (or methoxy)-isoquinolin-1(2H)-ones as novel EGFR inhibitor by scaffold hopping.
Kang BR; Shan AL; Li YP; Xu J; Lu SM; Zhang SQ
Bioorg Med Chem; 2013 Nov; 21(22):6956-64. PubMed ID: 24094432
[TBL] [Abstract][Full Text] [Related]
31. Unligated epidermal growth factor receptor forms higher order oligomers within microclusters on A431 cells that are sensitive to tyrosine kinase inhibitor binding.
Clayton AH; Tavarnesi ML; Johns TG
Biochemistry; 2007 Apr; 46(15):4589-97. PubMed ID: 17381163
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.
Waterson AG; Petrov KG; Hornberger KR; Hubbard RD; Sammond DM; Smith SC; Dickson HD; Caferro TR; Hinkle KW; Stevens KL; Dickerson SH; Rusnak DW; Spehar GM; Wood ER; Griffin RJ; Uehling DE
Bioorg Med Chem Lett; 2009 Mar; 19(5):1332-6. PubMed ID: 19208477
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases.
Xu G; Searle LL; Hughes TV; Beck AK; Connolly PJ; Abad MC; Neeper MP; Struble GT; Springer BA; Emanuel SL; Gruninger RH; Pandey N; Adams M; Moreno-Mazza S; Fuentes-Pesquera AR; Middleton SA; Greenberger LM
Bioorg Med Chem Lett; 2008 Jun; 18(12):3495-9. PubMed ID: 18508264
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
Meng D; Shi X; Jiang BH; Fang J
Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
[TBL] [Abstract][Full Text] [Related]
35. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
Wang CY; Wang YT; Tzeng DW; Yang JL
Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of normal, paramalignant, and malignant human urothelial cells to inhibitors of the epidermal growth factor receptor signaling pathway.
MacLaine NJ; Wood MD; Holder JC; Rees RW; Southgate J
Mol Cancer Res; 2008 Jan; 6(1):53-63. PubMed ID: 18234962
[TBL] [Abstract][Full Text] [Related]
37. Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
Mastalerz H; Chang M; Gavai A; Johnson W; Langley D; Lee FY; Marathe P; Mathur A; Oppenheimer S; Tarrant J; Tokarski JS; Vite GD; Vyas DM; Wong H; Wong TW; Zhang H; Zhang G
Bioorg Med Chem Lett; 2007 May; 17(10):2828-33. PubMed ID: 17368025
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells.
Basappa ; Ananda Kumar CS; Nanjunda Swamy S; Sugahara K; Rangappa KS
Bioorg Med Chem; 2009 Jul; 17(14):4928-34. PubMed ID: 19556138
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation.
Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS
Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059
[TBL] [Abstract][Full Text] [Related]
40. The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists.
Balog A; Salvati ME; Shan W; Mathur A; Leith LW; Wei DD; Attar RM; Geng J; Rizzo CA; Wang C; Krystek SR; Tokarski JS; Hunt JT; Gottardis M; Weinmann R
Bioorg Med Chem Lett; 2004 Dec; 14(24):6107-11. PubMed ID: 15546739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
